These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38502236)

  • 1. A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature.
    Maeser A; Biernacka-Zielinska M; Smolewska E
    Rheumatol Int; 2024 Nov; 44(11):2607-2612. PubMed ID: 38502236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anakinra and hepatotoxicity in pediatric rheumatology: a case series.
    Martins FR; Azevedo AC; Ganhão S; Aguiar F; Rodrigues M; Brito I
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):112. PubMed ID: 37803456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature.
    Sönmez HE; Demir S; Bilginer Y; Özen S
    Clin Rheumatol; 2018 Dec; 37(12):3329-3335. PubMed ID: 29663156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic onset juvenile idiopathic arthritis: a single center experience.
    Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
    Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
    Wagner-Weiner L
    Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Boom V; Anton J; Lahdenne P; Quartier P; Ravelli A; Wulffraat NM; Vastert SJ
    Pediatr Rheumatol Online J; 2015 Dec; 13():55. PubMed ID: 26634252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
    Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
    World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
    Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
    Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of coronary artery complication in a child with systemic juvenile idiopathic arthritis and macrophage activation syndrome: case report and literature review.
    Zhang L; Wei Y; Zeng N; Wang L; Chen X; Yang J; Xiao X
    Pediatr Rheumatol Online J; 2024 Jan; 22(1):4. PubMed ID: 38166957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis with co-existing pneumonia.
    Shi L; Hu F; Xu C; Zhu H; Qie D; Yuan C; Tao Y; Liu H
    Int J Rheum Dis; 2018 May; 21(5):1142-1145. PubMed ID: 28328098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
    Toplak N; Blazina Š; Avčin T
    Drug Des Devel Ther; 2018; 12():1633-1643. PubMed ID: 29922038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
    Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Gorelik M; Fall N; Altaye M; Barnes MG; Thompson SD; Grom AA; Hirsch R
    J Rheumatol; 2013 Jul; 40(7):1191-9. PubMed ID: 23678162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
    Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
    Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy.
    Ulu K; Aliyev E; Kılıç Könte E; Tanatar A; Türkmen Ş; Doğantan Ş; Kızıldağ Z; Kasap Demir B; Gezgin Yıldırım D; Otar Yener G; Öztürk K; Baba Ö; Açarı C; Kılbaş G; Taşkın SN; Haşlak F; Çağlayan Ş; Bağlan E; Dundar HA; Başaran Ö; Barut K; Karadağ ŞG; Coşkuner T; Sönmez HE; Yüksel S; Kalyoncu M; Bakkaloğlu SA; Ünsal E; Paç Kısaarslan A; Bilginer Y; Aktay Ayaz N; Kasapçopur Ö; Özen S; Sözeri B
    Rheumatology (Oxford); 2024 Sep; 63(SI2):SI167-SI172. PubMed ID: 38441301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of macrophage activation syndrome successfully treated with anakinra.
    Kelly A; Ramanan AV
    Nat Clin Pract Rheumatol; 2008 Nov; 4(11):615-20. PubMed ID: 18825135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
    Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
    J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.